Concert Wealth Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-13,263
Closed -$64K 1013
2016
Q2
$64K Sell
13,263
-1,985
-13% -$11.2K 0.01% 656
2016
Q1
$179K Buy
15,248
+1,107
+8% +$15.4K 0.02% 602
2015
Q4
$281K Sell
14,141
-1,125
-7% -$27.8K 0.04% 488
2015
Q3
$371K Buy
15,266
+669
+5% +$17.4K 0.05% 424
2015
Q2
$371K Buy
14,597
+503
+4% +$13.3K 0.05% 432
2015
Q1
$3K Buy
14,094
+1,111
+9% +$28.1K ﹤0.01% 483
2014
Q4
$289K Buy
12,983
+99
+0.8% +$2.58K 0.04% 468
2014
Q3
$355K Sell
12,884
-20
-0.2% -$604 0.05% 346
2014
Q2
$399K Buy
12,904
+282
+2% +$8.39K 0.05% 340
2014
Q1
$323K Buy
12,622
+85
+0.7% +$2.32K 0.04% 387
2013
Q4
$327K Buy
12,537
+207
+2% +$5.78K 0.04% 355
2013
Q3
$337K Sell
12,330
-1,982
-14% -$62.3K 0.05% 340
2013
Q2
$521K Buy
+14,312
New +$514K 0.08% 219

Other funds holding CLMT

Concert Wealth Management's CLMT Position: Q3 2016 in Review

Concert Wealth Management sold out of Calumet Specialty Products (CLMT) in Q3 2016, closing a stake of 13,263 shares — an estimated $64K sold.

Concert Wealth Management first reported a position in CLMT in Q2 2013 and held it in 13 quarters. The position peaked at $521K in Q2 2013. 93 funds tracked by Wall St. Rank hold CLMT as of Q3 2016.

  • Concert Wealth Management reported no remaining Calumet Specialty Products position as of Q3 2016 after selling out during the quarter.
  • Concert Wealth Management sold 13,263 Calumet Specialty Products shares in Q3 2016, an estimated $64K.
  • Concert Wealth Management first reported a position in Calumet Specialty Products in Q2 2013 and held it in 13 quarters.
  • Concert Wealth Management's Calumet Specialty Products position peaked at $521K in Q2 2013.
  • 93 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2016.

Based on Concert Wealth Management's 13F filing for Q3 2016, filed 27 Oct 2016.